MyFinsight
Home
Blog
About
Back
Balance Sheet
Petros Pharmaceuticals, Inc. (PTPI)
Petros Pharmaceuticals, Inc. (PTPI)
source: myfinsight.com
Cash and cash
equivalents
$3,488,595
(-52.35%↓ Y/Y)
Prepaid expenses and
other current assets
$57,124
(-24.18%↓ Y/Y)
Total current assets
$3,545,719
(-52.06%↓ Y/Y)
Total assets
$3,545,719
(-52.06%↓ Y/Y)
Total liabilities,
temporary equity and...
$3,545,719
(-52.06%↓ Y/Y)
Total liabilities
$2,844,825
(-3.56%↓ Y/Y)
Total stockholders'
equity
$700,894
(-84.24%↓ Y/Y)
Accumulated deficit
-$113,237,437
(-2.91%↓ Y/Y)
Total current
liabilities
$2,844,825
(-3.56%↓ Y/Y)
Additional paid-in capital
$113,934,094
(-0.48%↓ Y/Y)
Common stock (par value
0.0001 per share,...
$4,237
(0.21%↑ Y/Y)
Accrued series a
convertible redeemable...
$2,530,999
(47.52%↑ Y/Y)
Accrued expenses
$216,544
(-16.91%↓ Y/Y)
Accounts payable
$97,282
(-89.97%↓ Y/Y)
Back